Vet Practice May 2015

  • Published on
    22-Jul-2016

  • View
    224

  • Download
    4

Embed Size (px)

DESCRIPTION

 

Transcript

  • MAY 2015 $6.95 GST INCL.

    Discover Drs Michael Heath and Lisa Sanders generous spirit and their desire to eradicate rabies, page 24

    SPECIAL REPORTOur guide to the 2015 Pan Pacific

    conference, page 31

    Indian chiefs

    How to negotiate fair wages, page 18

    21st-century petsWhat you can do to slow the obesity epidemic, page 14

    Net benefitsWhy you should consider conducting consultations over the internet, page 21

    What are you worth?

    PPRRAACCTTIICCEE

  • PREVICOX EXCEEDINGEXPECTATIONS

    MOVING AHEAD IN OA

    - C

    red

    its:

    JM

    Lab

    at

    1. Refer to PREVICOX product label for full claim details. 2. Merial Data on File, PR&D 84101. 3. McCann, M.E., Andersen, D.R., & Zhang, D. et al (2004) In vitro activity and in vivo effi cacy of a novel COX-2 inhibitor in dogs. Am J Vet Res 65 :502-512 * When used according to label directions. Merial Australia Pty Ltd, Building D, 12-24 Talavera Road, Macquarie Park, NSW 2113. ABN 53 071 187 285. PREVICOX is a registered trademark of Merial. 2015 Merial Limited. All rights reserved. PREV.15.02.0051.

    PREVICOX RELIEVES PAIN WITH Once daily dosing - with or without food1

    Fast acting comfort - peak plasma levels achieved within90 minutes of dosing2

    Safety - high COX-2 selectivity while sparing COX-1 at therapeutic doses3*

    Dogs suffering from osteoarthritis need proven relief from pain and infl ammation.

    Prev Exceed Exp Trade ad_Provet.indd 1 31/03/2015 9:27 am

  • MAY 2015

    News + eventsSouth Australia leads charge 8SA announces comprehensive animal welfare reforms; Million PAWS Walk; botulism warning, and more ...

    Cover storyA passage to India 24How an Australian veterinary couple are helping India eradicate rabies

    Your worldAn obesity crisis 14Caring for 21st-century pets

    Your businessPay day 18Experts reveal how to negotiate your income

    Virtual reality 21Online consultations have great potential to improve patient care

    Vets in motion 28Why its worth considering a mobile vet practice

    Your toolsNew products 12The latest and greatest gear for your practice

    Product guide 31Vet Practice magazines guide to the best products at the 2015 Pan Pacific conference

    Tools of the trade 52Reviewed by your peers

    Your lifeAll fired up 54After joining the Rural Fire Service, Dr Anna Pillich of Kulnura Veterinary Clinic in NSW became one of the first female deputy captains in her area

    Contents

    CONTENTS

    24

    18

    28 54

    PRACTICE Editorial Director Rob Johnson

    Sub-editor Kerryn Ramsey

    Editor Nicole Hogan

    Digital Director Ann Gordon

    Art Director Lucy Glover

    Contributors John Burfitt, Akash Arora, Sue Nelson, Nicole Szollos

    Commercial Director Mark Brown

    For all editorial or advertising enquiries:Phone (02) 9660 6995 Fax (02) 9518 5600info@vetpracticemag.com.au

    Vet Practice magazine is published 11 times a year by Engage Media, Suite 4.17, 55 Miller Street, Pyrmont NSW 2009. ABN 50 115 977 421. Views expressed in Vet Practice magazine are not necessarily those of the publisher, editor or Engage Media. Printed by Webstar.

    21

    14

    Sales Director Adam Cosgrove

    4,517 - CAB Audited as at September 2014

    PREVICOX EXCEEDINGEXPECTATIONS

    MOVING AHEAD IN OA

    - C

    red

    its:

    JM

    Lab

    at

    1. Refer to PREVICOX product label for full claim details. 2. Merial Data on File, PR&D 84101. 3. McCann, M.E., Andersen, D.R., & Zhang, D. et al (2004) In vitro activity and in vivo effi cacy of a novel COX-2 inhibitor in dogs. Am J Vet Res 65 :502-512 * When used according to label directions. Merial Australia Pty Ltd, Building D, 12-24 Talavera Road, Macquarie Park, NSW 2113. ABN 53 071 187 285. PREVICOX is a registered trademark of Merial. 2015 Merial Limited. All rights reserved. PREV.15.02.0051.

    PREVICOX RELIEVES PAIN WITH Once daily dosing - with or without food1

    Fast acting comfort - peak plasma levels achieved within90 minutes of dosing2

    Safety - high COX-2 selectivity while sparing COX-1 at therapeutic doses3*

    Dogs suffering from osteoarthritis need proven relief from pain and infl ammation.

    Prev Exceed Exp Trade ad_Provet.indd 1 31/03/2015 9:27 am

  • DP-50VetOnly $8,000RRP: $9,500 Ideal for the general practice

    environment

    Package Includes the following:

    Mindray DP-50Vet Ultrasound System1x Transducer of choice

    Sale Price $8,000 (RRP $9,500)

    Visit BCF at stand #104 for a range of deals www.bcfultrasound.com or call us on 1300 798 747

    DP-10VetLightweight, portable ultrasound system(RRP: $4,200)

    DP-30VetYour ideal Equine Reproductive Tool(RRP: $8,600)

    Z5VetAffordable Colour Doppler System(RRP: $12,000)

    Z6VetSuperior image quality, Colour and Pulsed Wave Doppler. (RRP: $16,000)

    $9,500

    $13,500

    $3,500

    ConferencePanPac

    More great ultrasound + probe deals.....

    $7,950

    Free Bag & Battery

    *Prices are in AUD and exclude GST/Freight and are only available until 30th June 2015 or while stocks last. Package prices include System and 1x compatible transducer. Contact BCF Ultrasound for full terms and conditions.

    Stand #104

    AUS 1300 798 747 | NZ +64 9 257 1212sales@bcfultrasound.com | www.bcfultrasound.com

    Vetpractice PanPac 2015.indd 1 6/05/2015 2:43 pm

  • DP-50VetOnly $8,000RRP: $9,500 Ideal for the general practice

    environment

    Package Includes the following:

    Mindray DP-50Vet Ultrasound System1x Transducer of choice

    Sale Price $8,000 (RRP $9,500)

    Visit BCF at stand #104 for a range of deals www.bcfultrasound.com or call us on 1300 798 747

    DP-10VetLightweight, portable ultrasound system(RRP: $4,200)

    DP-30VetYour ideal Equine Reproductive Tool(RRP: $8,600)

    Z5VetAffordable Colour Doppler System(RRP: $12,000)

    Z6VetSuperior image quality, Colour and Pulsed Wave Doppler. (RRP: $16,000)

    $9,500

    $13,500

    $3,500

    ConferencePanPac

    More great ultrasound + probe deals.....

    $7,950

    Free Bag & Battery

    *Prices are in AUD and exclude GST/Freight and are only available until 30th June 2015 or while stocks last. Package prices include System and 1x compatible transducer. Contact BCF Ultrasound for full terms and conditions.

    Stand #104

    AUS 1300 798 747 | NZ +64 9 257 1212sales@bcfultrasound.com | www.bcfultrasound.com

    Vetpractice PanPac 2015.indd 1 6/05/2015 2:43 pm

    EQUINE VETERINARIANS AUSTRALIA (EVA) has a membership of over 1,000, and is the peak professional association representing Australias equine veterinarians. We write in regard to the April cover story, Hendra - The Vaccination Debate. For an article that the cover claims is an in-depth investigation covering the facts from vets and horse owners, the article was surprisingly lacking in depth, and suffered from very limited research. It was, in summary, a poor article. Your readership are professional veterinarians, together with their clinical staff; these are highly educated people, who expect a high standard of journalism from a magazine purporting to investigate and report on the issues confronting a veterinary practice today. EVA has now received numerous member complaints with regard to the article, and we are compelled to bring this to your attention and to ask for the right of reply in your next hard copy edition of Vet Practice Magazine.

    Hendra virus is a deadly and infectious disease which has killed people, and continues to kill horses on the east coast of Australia every year. Horse owners are fortunate that a safe and effective Hendra vaccine has now been developed by the CSIRO in Australia, in conjunction with internationally renowned, leading US scientists. The CSIRO is one of the worlds most internationally respected scientific research bodies. The Australian Governments Veterinary Medicine Authority, the APVMA, are the approving and regulatory authority for the vaccine; this vaccine has met the most stringent requirements of the APVMA, and was released for widespread use under APVMA Permit Number 14876. The article states that, the vaccines been released on a minor use permit, which means its supposed to be used to control outbreaks of the disease. The article

    also states that, until the vaccine is a registered product, it should be used as it states on its minor usage permit, which is purely around the disease itself to stop outbreaks. These assertions as fact are completely incorrect. The vaccine is permitted by the Australian Government for use in all areas of Australia, and your journalist should have, at the very least, checked the conditions of the Permit, which are readily available online, and quick to read.

    Your article states that, there are now growing concerns over the safety of the vaccine. Where is the evidence of this growing concern? Where is it growing? Over 350,000 doses of the vaccine have been administered; what numbers of growing concern did your journalists investigation uncover? What instrument did your journalist use to measure this claim? Are these results available for scrutiny, and are

    they statistically valid?Anti-vaccinationists exist in all walks

    of life. It appears that your journalist has relied on a combination of rumours, anecdotes, commentary and innuendo sourced from social media. Any assertion or assumption by your journalist or others that comment sourced from social media is a true representation of scientific fact is a dangerous and invalid misinterpretation and misrepresentation. This has been well-demonstrated than in the United States, which is currently experiencing deaths in a human epidemic of measles. This epidemic could have been avoided if the people infected had been vaccinated with a safe and effective measles vaccine, and not been misled by ill-informed anti-vaccinationists using social media to distort the true scientific facts and benefits of a safe, efficacious vaccine. The same situation has occurred in Australia with

    L E T T E R T O T H E E D I T O R

    5

    Dear Editor

    COVER STORY

    18

    Pho

    tog

    rap

    hy:

    CS

    IRO

    19

    have been growing unverified reports

    of horses having adverse reactions to

    the injections, ranging from localised

    swelling, hair loss, rashes and fever, to

    colic, and horses dropping dead in the

    days following the vaccine.

    Seven horse deaths are currently being

    invested by the Australian Pesticides and

    Veterinary Medicines Authority (APVMA)

    for a possible link to the vaccine.

    While Zoetis claims that reactions

    are possible with any vaccine, theyve

    seen a reaction rate of less than 0.3 per

    centthats 960 reactions out of the

    320,000 vaccines administered so far.

    And the majority of these reactions are

    localised swelling at the injection site.

    Vicki Roycroft, a six-time Olympic

    equestrian rider, has seen many of these

    side effects first-hand, however,

    and believes that can be

    more severe than Zoetis

    describes.I knew a horse who,

    after the first injection,

    was so swollen that

    it couldnt feed in the

    paddock for a week.

    I understand a bit of a

    sore neck and swelling,

    but if a horse cant put their

    head down to feed, thats not

    right, she says.

    Shes also seen more severe

    reactions develop after subsequent

    boosters. A neighbours horse had a

    reaction the first time she gave him the

    vaccine, so she decided to inject it into

    his chest the next time. The next day

    he developed laminitis problems. Ive

    also seen horses getting really sick and

    horses are dying after the vaccine. Of

    course, the two could be unrelated, but

    there are too many coincidences.

    Equestrian rider Sue Vickery has had

    both of her horses react to the vaccine.

    The first two reactions were quite mild.

    The horses were off colour, not eating

    for 24 hours and very lethargic. The

    second reaction was far worse, with a

    temperature of 39 degrees for 24 hours,

    muscle soreness and swelling after a

    short walk. They didnt eat normal feed

    for four days, she says.

    My older horse is now 16 and has

    ongoing wind problems, green mucus

    continually comes out of one or other

    nostril at random, and he doesnt have

    the energy to be trained for more than

    10 to 15 minutes.

    All these reactions experienced by

    horses are reported by veterinarians

    to Zoetis, who then passes them onto

    the APVMA for investigation, which

    is standard practice for all animal

    pharmaceutical products in Australia.

    The vaccine itself has been thoroughly

    researchedits made up of a protein

    called sG, which helps the

    Hendra virus infect cells.

    Because it doesnt

    actually contain any of

    the live virus, theres

    no risk of infection

    from the vaccine.

    And veterinarian Dr

    Stephanie Armstrong,

    a spokesperson for

    Zoetis, explains that its

    safety isnt in question when

    used on a healthy horse

    over the age of four months.

    Equivac HeV went

    through the same safety and efficacy

    testing any vaccine goes through prior

    to being released, says Dr Armstrong.

    Efficacy was proved through challenge

    studies and serology studies, while safety

    studies were also completed. The vaccine

    performed very well in all studies.

    Dr Armstrong explains that all of the

    safety and trial information has been

    submitted to the APVMA, and that the

    vaccine has now been gazetted by

    the APVMA, which is one of the final

    steps before registration is finalised. A

    spokesperson from the APVMA added

    that this is a normal processing time for

    With growing concern over the safety of the

    Hendra vaccine, Fiona MacDonald talks to

    vets and horse owners to get the facts

    Inside the Hendra vaccine debate

    IN JULY 2009, DR ALISTER RODGERS

    was called out to a stud farm near

    Rockhampton, Queensland to examine

    a couple of horses that had fallen ill.

    The 55-year-old did a full physical

    and took blood samples, but couldnt

    determine what was wrong. A few

    days later, one of the fillies died,

    and the post-mortem confirmed that

    she was infected with the Hendra

    virus. Unfortunately, Rodgers had

    been exposed.

    He was rushed to hospital for

    anti-viral medication but his health

    quickly deteriorated, and at the

    start of September, he passed away,

    becoming the fourth person in

    Queensland to die from the Hendra

    virus since it was discovered in 1994,

    in addition to almost 100 horses.

    Rodgers death, which came just

    months after the death of another young

    Queensland vet, was met with renewed

    demand for protection against the virus.

    Hendra is transferred from bats to

    horses via bodily fluids, and then from

    horses to humans in the same way, and

    so vaccinating horses was determined

    the best way for us to stay safe.

    In 2012, after more than a decade of

    research by the CSIRO, an Equivac HeV

    was released, and the equine industry

    breathed a sigh of relief.

    Three years on, however, and the

    vaccine is still waiting to be registered

    by the Australian Pesticides and

    Veterinary Medicines Authority. Despite

    this fact, its already been widely pushed

    out by vets and event organisers across

    Australia. And there are now growing

    concerns over the safety of the vaccine,

    how necessary it is in areas that arent

    exposed to bats and also how often its

    being recommended.

    Early in 2014, vets reported that

    the uptake of the vaccine had been

    disappointingly slow. Most likely

    because the immunisation costs around

    $1...